SCHEMBL30301765

SCHEMBL30301765

CCOc1c(C)c(OS(=O)(=O)c2ccc(C)cc2)cc(OS(=O)(=O)c2ccc(C)cc2)c1C(=O)N1Cc2ccc(CN3CCN(C)CC3)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.46
HSP90AB1 P08238 2/20 0.46
HSP90B1 P14625 1/20 0.45
ALDH1A1 P00352 4/20 0.38
STAT3 P40763 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ROCK1 Q13464 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
GAA P10253 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
BDKRB1 P46663 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30301742 0.93 HSP90AA1 (0.45) HSP90AA1HSP90AB1HSP90B1ALDH1A1STAT3
SCHEMBL25221649 0.91 HSP90AA1 (0.42) HSP90AA1HSP90AB1HSP90B1ALDH1A1STAT3
SCHEMBL25248403 0.89 HSP90AA1 (0.40) HSP90AA1HSP90AB1HSP90B1ALDH1A1STAT3
SCHEMBL29263207 0.85 LMNA (0.40) HSP90AA1HSP90AB1ALDH1A1STAT3KDM4E
SCHEMBL25201795 0.83 P2RX7 (0.37) HSP90AA1HSP90AB1ALDH1A1KDM4EMEN1
SCHEMBL25228227 0.81 BDKRB1 (0.35) HSP90AA1HSP90AB1BDKRB1HTR6
SCHEMBL30462396 0.79 CA1 (0.36) ALDH1A1KDM4EMEN1KMT2ALMNA
SCHEMBL25228631 0.79 CA1 (0.36) ALDH1A1KDM4EMEN1KMT2ALMNA
SCHEMBL30301565 0.78 HSP90AA1 (0.62) HSP90AA1HSP90AB1HSP90B1ALDH1A1KDM4E
SCHEMBL30368050 0.77 HSP90AA1 (0.46) HSP90AA1HSP90AB1HSP90B1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4157463-A1 INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT Neophore Limited (GB) 2023-04-05 EP disclosed